Betta Pharmaceuticals Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 584.71 million compared to CNY 618.56 million a year ago. Revenue was CNY 584.71 million compared to CNY 618.56 million a year ago. Net income was CNY 83.68 million compared to CNY 147.75 million a year ago. Basic earnings per share from continuing operations was CNY 0.2 compared to CNY 0.36 a year ago. Diluted earnings per share from continuing operations was CNY 0.2 compared to CNY 0.35 a year ago.